20
Chemwerth Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
They are recognized for ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
One of their notable products is ABIRATERONE ACETATE, with a corresponding US DMF Number 26894.
Remarkably, this DMF maintains an Active status since its submission on July 30, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 13, 2014, and payment made on August 04, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II